Middle East and Africa Immunoassay Reagents and Devices Market - Industry Trends and Forecast To 2027

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 DBMR MARKET POSITION GRID

2.7 DBMR VENDOR SHARE ANALYSIS

2.8 MULTIVARIATE MODELING

2.9 PRODUCT TIMELINE CURVE

2.10 SECONDARY SOURCES

2.11 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 INDUSTRY INSIGHT

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 INCREASING PREVALENCE OF DISEASES

5.1.2 INCREASING APPLICATION OF DRUG SCREEINING TESTS

5.1.3 INCREASING HEALTHCARE EXPENDITURE

5.1.4 WIDE APPLICATION OF IMMUNOASSAY

5.2 RESTRAINTS

5.2.1 PRODUCT RECALL OF IMMUNOASSAY KITS AND DEVICES

5.2.2 STRINGENT REGULATIONS BY REGULATORY AUTHORITIES

5.2.3 HIGH COST ASSOCIATED WITH DEVICES

5.3 OPPORTUNITIES

5.3.1 INCREASE IN RESEARCH & DEVELOPMENT ACTIVITIES

5.3.2 STRATEGIC INITATIVES BY THE COMPANIES

5.3.3 TECHNOLOGICAL UPGRADATION AND ADVANCEMENTS IN BIOTECHNOLOGY

5.4 CHALLENGES

5.4.1 LACK OF AWARENESS AND SKILLS REGARDING THE USAGE OF TECHNOLOGY

5.4.2 COMPLEXICITY IN PERFORMING IMMUNOASSAY

5.4.3 AVAILABILITY OF SUBSTITUTE

6 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT

6.1 OVERVIEW

6.2 REAGENTS & KITS

6.2.1 ELISA REAGENTS & KITS

6.2.1.1 THIRD-GENERATION ELISA

6.2.1.2 FIFTH-GENERATION ELISA

6.2.1.3 FOURTH-GENERATION ELISA

6.2.1.4 FIRST-GENERATION ELISA

6.2.1.5 SECOND-GENERATION ELISA

6.2.2 ELISPOT REAGENTS & KITS

6.2.3 RAPID TEST REAGENTS & KITS

6.2.4 WESTERN BLOT REAGENTS & KITS

6.2.5 OTHER REAGENTS & KITS

6.3 ANALYZERS

6.3.1 BY TYPE

6.3.1.1 OPEN-ENDED SYSTEMS

6.3.1.2 CLOSED-ENDED SYSTEMS

6.3.2 BY DEVICE TYPE

6.3.2.1 BENCH-TOP

6.3.2.2 FLOOR STANDING

7 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM

7.1 OVERVIEW

7.2 ENZYME IMMUNOASSAY

7.3 FLUORESCENCE IMMUNOASSAYS

7.4 CHEMILUMINESCENCE IMMUNOASSAYS

7.5 RADIOIMMUNOASSAYS

7.6 OTHERS

8 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE

8.1 OVERVIEW

8.2 ENZYME-LINKED IMMUNOSORBENT ASSAYS

8.3 ENZYME-LINKED IMMUNOSPOT

8.4 RAPID TESTS

8.5 WESTERN BLOTTING

8.6 IMMUNO-PCR

8.7 OTHER TECHNIQUES

9 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE

9.1 OVERVIEW

9.2 BLOOD

9.3 URINE

9.4 SALIVA

9.5 OTHERS

10 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION

10.1 OVERVIEW

10.2 ONCOLOGY AND ENDOCRINOLOGY

10.3 HEMATOLOGY & BLOOD SCREENING

10.4 CARDIOLOGY

10.5 INFECTIOUS DISEASES

10.6 BONE & MINERAL DISORDERS

10.7 AUTOIMMUNE DISORDERS

10.8 TOXICOLOGY

10.9 NEONATAL SCREENING

10.10 OTHER APPLICATIONS

11 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER

11.1 OVERVIEW

11.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES

11.3 CLINICAL LABORATORIES

11.4 HOSPITALS

11.5 RESEARCH & ACADEMIC LABORATORIES

11.6 BLOOD BANKS

11.7 OTHERS

12 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY GEOGRAPHY

12.1 MIDDLE EAST & AFRICA

12.1.1 SAUDI ARABIA

12.1.2 SOUTH AFRICA

12.1.3 EGYPT

12.1.4 UAE

12.1.5 ISRAEL

12.1.6 REST OF MIDDLE EAST & AFRICA

13 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA

14 COMPANY PROFILES

14.1 F. HOFFMANN-LA ROCHE LTD

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 COMPANY SHARE ANALYSIS

14.1.4 PRODUCT PORTFOLIO

14.1.5 RECENT DEVELOPMENT

14.2 BIO-RAD LABORATORIES, INC.

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 COMPANY SHARE ANALYSIS

14.2.4 PRODUCT PORTFOLIO

14.2.5 RECENT DEVELOPMENTS

14.3 BIOMÉRIEUX SA

14.3.1 COMPANY SNAPSHOT

14.3.2 REVENUE ANALYSIS

14.3.3 COMPANY SHARE ANALYSIS

14.3.4 PRODUCT PORTFOLIO

14.3.5 RECENT DEVELOPMENT

14.4 ABBOTT

14.4.1 COMPANY SNAPSHOT

14.4.2 REVENUE ANALYSIS

14.4.3 COMPANY SHARE ANALYSIS

14.4.4 PRODUCT PORTFOLIO

14.4.5 RECENT DEVELOPMENTS

14.5 RANDOX LABORATORIES LTD.

14.5.1 COMPANY SNAPSHOT

14.5.2 PRODUCT PORTFOLIO

14.5.3 RECENT DEVELOPMENT

14.6 AGILENT TECHNOLOGIES, INC.

14.6.1 COMPANY SNAPSHOT

14.6.2 REVENUE ANALYSIS

14.6.3 PRODUCT PORTFOLIO

14.6.4 RECENT DEVELOPMENT

14.7 LUMINEX CORPORATION

14.7.1 COMPANY SNAPSHOT

14.7.2 REVENUE ANALYSIS

14.7.3 PRODUCT PORTFOLIO

14.7.4 RECENT DEVELOPMENT

14.8 BD

14.8.1 COMPANY SNAPSHOT

14.8.2 REVENUE ANALYSIS

14.8.3 PRODUCT PORTFOLIO

14.8.4 RECENT DEVELOPMENT

14.9 BECKMAN COULTER, INC.

14.9.1 COMPANY SNAPSHOT

14.9.2 REVENUE ANALYSIS

14.9.3 PRODUCT PORTFOLIO

14.9.4 RECENT DEVELOPMENT

14.10 BIOCHECK, INC.

14.10.1 COMPANY SNAPSHOT

14.10.2 PRODUCT PORTFOLIO

14.10.3 RECENT DEVELOPMENT

14.11 BIO-TECHNE

14.11.1 COMPANY SNAPSHOT

14.11.2 REVENUE ANALYSIS

14.11.3 PRODUCT PORTFOLIO

14.11.4 RECENT DEVELOPMENTS

14.12 DIASORIN S.P.A.

14.12.1 COMPANY SNAPSHOT

14.12.2 PRODUCT PORTFOLIO

14.12.3 RECENT DEVELOPMENTS

14.13 MERCK KGAA

14.13.1 COMPANY SNAPSHOT

14.13.2 REVENUE ANALYSIS

14.13.3 PRODUCT PORTFOLIO

14.13.4 RECENT DEVELOPMENTS

14.14 MESO SCALE DIAGNOSTICS, LLC

14.14.1 COMPANY SNAPSHOT

14.14.2 PRODUCT PORTFOLIO

14.14.3 RECENT DEVELOPMENTS

14.15 ORTHO CLINICAL DIAGNOSTICS (A SUBSIDIARY OF CARLYLE INVESTMENT MANAGEMENT L.L.C)

14.15.1 COMPANY SNAPSHOT

14.15.2 REVENUE ANALYSIS

14.15.3 PRODUCT PORTFOLIO

14.15.4 RECENT DEVELOPMENT

14.16 PERKINELMER INC.

14.16.1 COMPANY SNAPSHOT

14.16.2 REVENUE ANALYSIS

14.16.3 PRODUCT PORTFOLIO

14.16.4 RECENT DEVELOPMENT

14.17 QIAGEN

14.17.1 COMPANY SNAPSHOT

14.17.2 REVENUE ANALYSIS

14.17.3 PRODUCT PORTFOLIO

14.17.4 RECENT DEVELOPMENT

14.18 QUIDEL CORPORATION

14.18.1 COMPANY SNAPSHOT

14.18.2 REVENUE ANALYSIS

14.18.3 PRODUCT PORTFOLIO

14.18.4 RECENT DEVELOPMENT

14.19 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.

14.19.1 COMPANY SNAPSHOT

14.19.2 PRODUCT PORTFOLIO

14.19.3 RECENT DEVELOPMENTS

14.20 SIEMENS

14.20.1 COMPANY SNAPSHOT

14.20.2 REVENUE ANALYSIS

14.20.3 PRODUCT PORTFOLIO

14.20.4 RECENT DEVELOPMENTS

14.21 SYSMEX CORPORATION

14.21.1 COMPANY SNAPSHOT

14.21.2 REVENUE ANALYSIS

14.21.3 PRODUCT PORTFOLIO

14.21.4 RECENT DEVELOPMENTS

14.22 THERMO FISHER SCIENTIFIC INC.

14.22.1 COMPANY SNAPSHOT

14.22.2 REVENUE ANALYSIS

14.22.3 PRODUCT PORTFOLIO

14.22.4 RECENT DEVELOPMENTS

15 QUESTIONNAIRE

16 RELATED REPORTS

UU

TABLE 1 COST OF EIA KITS BY MERCK KGAA

TABLE 2 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 3 MIDDLE EAST & AFRICA REAGENTS AND KITS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 4 MIDDLE EAST & AFRICA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 5 MIDDLE EAST & AFRICA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 6 MIDDLE EAST & AFRICA ANALYZERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 7 MIDDLE EAST & AFRICA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 8 MIDDLE EAST & AFRICA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2018-2027 (USD MILLION)

TABLE 9 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2018-2027 (USD MILLION)

TABLE 10 MIDDLE EAST & AFRICA ENZYME IMMUNOASSAY IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 11 MIDDLE EAST & AFRICA FLUORESCENCE IMMUNOASSAYS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 12 MIDDLE EAST & AFRICA CHEMILUMINESCENCE IMMUNOASSAYS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 13 MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 14 MIDDLE EAST & AFRICA OTHERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 15 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 16 MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAYS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 17 MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSPOT IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 18 MIDDLE EAST & AFRICA RAPID TESTS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 19 MIDDLE EAST & AFRICA WESTERN BLOTTING IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 20 MIDDLE EAST & AFRICA IMMUNO-PCR IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 21 MIDDLE EAST & AFRICA OTHER TECHNIQUES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2018-2027 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA BLOOD IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 24 MIDDLE EAST & AFRICA URINE IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 25 MIDDLE EAST & AFRICA SALIVA IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 26 MIDDLE EAST & AFRICA OTHERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 27 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)

TABLE 28 MIDDLE EAST & AFRICA ONCOLOGY AND ENDOCRINOLOGY IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 29 MIDDLE EAST & AFRICA HEMATOLOGY & BLOOD SCREENING IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 30 MIDDLE EAST & AFRICA CARDIOLOGY IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA INFECTIOUS DISEASES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA BONE & MINERAL DISORDERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA AUTOIMMUNE DISORDERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 34 MIDDLE EAST & AFRICA TOXICOLOGY IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 35 MIDDLE EAST & AFRICA NEONATAL SCREENING IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 36 MIDDLE EAST & AFRICA OTHER APPLICATIONS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 37 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 38 MIDDLE EAST & AFRICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 39 MIDDLE EAST & AFRICA CLINICAL LABORATORIES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA HOSPITALS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA RESEARCH & ACADEMIC LABORATORIES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA BLOOD BANKS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA OTHERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 44 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 45 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 46 MIDDLE EAST & AFRICA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 47 MIDDLE EAST & AFRICA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2018-2027 (USD MILLION)

TABLE 48 MIDDLE EAST & AFRICA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 49 MIDDLE EAST & AFRICA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 50 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2018-2027 (USD MILLION)

TABLE 51 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 52 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2018-2027 (USD MILLION)

TABLE 53 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)

TABLE 54 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 55 SAUDI ARABIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 56 SAUDI ARABIA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 57 SAUDI ARABIA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2018-2027 (USD MILLION)

TABLE 58 SAUDI ARABIA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 59 SAUDI ARABIA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 60 SAUDI ARABIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2018-2027 (USD MILLION)

TABLE 61 SAUDI ARABIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 62 SAUDI ARABIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2018-2027 (USD MILLION)

TABLE 63 SAUDI ARABIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)

TABLE 64 SAUDI ARABIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 65 SOUTH AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 66 SOUTH AFRICA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 67 SOUTH AFRICA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2018-2027 (USD MILLION)

TABLE 68 SOUTH AFRICA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 69 SOUTH AFRICA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 70 SOUTH AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2018-2027 (USD MILLION)

TABLE 71 SOUTH AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 72 SOUTH AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2018-2027 (USD MILLION)

TABLE 73 SOUTH AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)

TABLE 74 SOUTH AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 75 EGYPT IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 76 EGYPT ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 77 EGYPT ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2018-2027 (USD MILLION)

TABLE 78 EGYPT REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 79 EGYPT ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 80 EGYPT IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2018-2027 (USD MILLION)

TABLE 81 EGYPT IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 82 EGYPT IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2018-2027 (USD MILLION)

TABLE 83 EGYPT IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)

TABLE 84 EGYPT IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 85 UAE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 86 UAE ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 87 UAE ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2018-2027 (USD MILLION)

TABLE 88 UAE REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 89 UAE ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 90 UAE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2018-2027 (USD MILLION)

TABLE 91 UAE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 92 UAE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2018-2027 (USD MILLION)

TABLE 93 UAE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)

TABLE 94 UAE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 95 ISRAEL IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 96 ISRAEL ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 97 ISRAEL ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2018-2027 (USD MILLION)

TABLE 98 ISRAEL REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 99 ISRAEL ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 100 ISRAEL IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2018-2027 (USD MILLION)

TABLE 101 ISRAEL IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 102 ISRAEL IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2018-2027 (USD MILLION)

TABLE 103 ISRAEL IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)

TABLE 104 ISRAEL IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 105 REST OF MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)